Gian Paolo Rossi
Gian Paolo Rossi is an expert in Cardiology at University of Padua (Italy). As of October 2026, ScienceLeadR ranks Gian Paolo Rossi in the top 1% of experts worldwide for Adrenal Gland Diseases, Hypertension and Adenoma. Gian Paolo Rossi has authored 532 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 1,962 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Endocrinology - Hematology - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1992 - 2026
Number : 532
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months. PMID 42483794 — hypertension, aldosterone, cardiovascular diseases, blood pressure, hyperaldosteronism, renin, therapeutics, hemodynamics | Hypertension | 2026 | 0 |
| Cytosolic Calcium Oscillations in Human Adrenocortical Cells Causing Primary Aldosteronism. PMID 42431251 — cells, aldosterone, hyperaldosteronism, hormones, calcium | Mol Cell Endocrinol | 2026 | 0 |
| Letter to the Editor: Contralateral suppression indices and the need for outcome-based reference standards in primary aldosteronism. PMID 42413817 — hyperaldosteronism, radiology, interventional | J Vasc Interv Radiol | 2026 | 0 |
| Aldosterone synthase inhibitors for the treatment of cardiovascular disease. PMID 42174224 — hypertension, aldosterone, blood, cytochrome p-450 cyp11b2, cardiovascular diseases, blood pressure, receptors, mineralocorticoid, therapeutics, mineralocorticoids | Nat Rev Endocrinol Top journal | 2026 | 0 |
| Subtyping of Primary Aldosteronism in Partial Adrenal Vein Sampling: The Relative Aldosterone Secretion Index. PMID 42089127 — aldosterone, blood pressure, hyperaldosteronism, adrenalectomy, diagnosis, veins, hemodynamics | Hypertension | 2026 | 0 |
Clinical Studies 9
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn NCT06090617 — skin, hypertension, aldosterone, blood, essential hypertension, blood pressure, glycosaminoglycans, adrenocortical adenoma, biopsy, hyperaldosteronism, renin, adrenal hyperplasia, congenital, angiotensins, adrenalectomy, adrenogenital syndrome, adenoma, hyperplasia | N/A | Recruiting | 2021 |
| Efficacy of Nafamostat in Covid 19 Patients (RACONA Study) NCT04352400 — mesylates, serine proteases, coronavirus, covid-19, peptide hydrolases, names, random allocation, serine | Phase 2/Phase 3 | Recruiting | 2021 |
LeadR Networks
Main global connection map